Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -OECD Digital Tax Project (Global Minimum Tax Implementation) -Strengthening Benefit Plans Act (S. 2003) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 Oral Health Products Inclusion Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2026 · third_quarter · Q3
-Issues related to FAA Taxiway designations for local airports
-Issues related to Generally Recognized As Safe designation (no bill)
Source: Senate LDA
-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 - Oral Health Products Inclusion Act
Oral Health Products Inclusion Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 - Oral Health Products Inclusion Act
Oral Health Products Inclusion Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -OECD Digital Tax Project (Global Minimum Tax Implementation) -Strengthening Benefit Plans Act (S. 2003) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 Oral Health Products Inclusion Act
Oral Health Products Inclusion Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to Generally Recognized as Safe (GRAS) and Additive Ingredients Regulation -H.R. 1219, Oral Health Products Inclusion Act -Issues related to New Approach Methodologies (NAMs) non-animal technologies used to evaluate drug safety and efficacy
-Issues Related to Product Safety and Quality Assurance (No Bill) -Issues related to Labeling of Menstrual Products -PACK Act (Packaging and Claims Knowledge Act) HR 6832
BUILD America 250 Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R.8870 - BUILD America 250 Act (gross vehicle weight limit pilot program provision)
Strengthening Benefit Plans Act of 2025
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -OECD Digital Tax Project (Global Minimum Tax Implementation) -Strengthening Benefit Plans Act (S. 2003) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 Oral Health Products Inclusion Act
Oral Health Products Inclusion Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
Over-the-Counter Monograph Drug User Fee Amendments
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R.4273: Over-the-Counter Monograph Drug User Fee Amendments (Entire Bill)
Over-the-Counter Monograph Drug User Fee Amendments
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act
Over-the-Counter Monograph Drug User Fee Amendments
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
Oral Health Products Inclusion Act
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 8599, Oral Health Products Inclusion Act
-H.R. 471, the SHIP IT Act
-H.R. 471, the SHIP IT Act
-H.R. 471, the SHIP IT Act
-H.R.471 The SHIP IT Act
American Privacy Rights Act of 2024
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
American Privacy Rights Act of 2024
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
American Privacy Rights Act of 2024
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
Freedom To Compete Act of 2023
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to labor and employment policy -S.379, Freedom To Compete Act of 2023
-S.1350: WIPPES Act -H.R.2964: WIPPES Act -Issues related to environmental sustainability
Menstrual Equity For All Act of 2023
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to maternal health, maternal health equity, black maternal health -Issues related to access to menstrual products (no bill introduced) -Issues related to menstrual products labeling (no bill introduced) -H.R.3646 - Menstrual Equity For All Act of 2023 -H.R.8829 - Menstrual Products Right To Know Act of 2022
- H.R.471 SHIP IT Act
-H.R.471: The SHIP IT Act -Issues related to sustainability innovations in the transportation sector (no bill) -Issues related to intermodal transportation and supply chain challenges (no bill)
- H.R.471 SHIP IT Act
-S.1350: WIPPES Act -H.R.2964: WIPPES Act -Issues related to environmental sustainability
To codify the denial of export privileges and related provisions under title 15, Code of Federal Regulations.
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
To codify the denial of export privileges and related provisions under title 15, Code of Federal Regulations.
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to cleaning products ingredient labeling disclosure bill (no bill introduced) -S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
Menstrual Products Right To Know Act of 2022
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to maternal health, maternal health equity, black maternal health -Issues related to access to menstrual products (no bill introduced) -Issues related to menstrual products labeling (no bill introduced) -H.R.3646 - Menstrual Equity For All Act of 2023 -H.R.8829 - Menstrual Products Right To Know Act of 2022
National Risk Management Act of 2021
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to cleaning products ingredient labeling disclosure bill (no bill introduced) -S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
National Risk Management Act of 2021
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
-Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -OECD Digital Tax Project (Global Minimum Tax Implementation) -Strengthening Benefit Plans Act (S. 2003) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 Oral Health Products Inclusion Act
-Issues related to Ingredient Regulations (no bill)
-Issues related to FDA review of active ingredients in over-the-counter products
-Issues Related to Product Safety and Quality Assurance (No Bill)
-Issues related to counterfeit products/illicit trade/cargo theft -Section 338 Canada Tariffs -Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 122 Balance of Payment Tariffs -Section 301 Excess Capacity/Forced Labor Investigations -U.S.-China Board of Trade
-H.R.8870 - BUILD America 250 Act (gross vehicle weight limit pilot program provision)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2026 · second_quarter · Q2
-Issues Related to Product Safety and Quality Assurance (No Bill) -Issues related to Labeling of Menstrual Products -PACK Act (Packaging and Claims Knowledge Act) HR 6832
-Issues related to Generally Recognized as Safe (GRAS) and Additive Ingredients Regulation -H.R. 1219, Oral Health Products Inclusion Act -Issues related to New Approach Methodologies (NAMs) non-animal technologies used to evaluate drug safety and efficacy
-Issues related to FDA review of active ingredients in over-the-counter products
-Issues related to the SHIP IT Act
-Section 232 Steel/Aluminum Trade Investigation -Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 122 Balance of Payment Tariffs -Section 301 Excess Capacity/Forced Labor Investigations -Medical Devices/PPE Section 232 Investigation -U.S.-China Board of Trade -Industrial Machinery Section 232 Investigation -Issues related to counterfeit products/illicit trade
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2026 · first_quarter · Q1
-Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 232 Pharmaceuticals Trade Investigation -Section 232 Semiconductors Trade Investigation -Section 232 Softwood Lumber Trade Investigation -Section 232 Medical Devices/PPE Trade Investigation -IEEPA Reciprocal Tariffs -Section 232 Industrial Machinery Trade Investigation -Section 122 Balance of Payment Tariffs -Section 232 Steel/Aluminum Trade Investigation -Section 301 Excess Capacity/Forced Labor Trade Investigation -Issues related to counterfeit products/illicit trade
-Issues Related to Product Safety and Quality Assurance (No Bill) -FDA Menstrual Products Guidance
-Issues related to Generally Recognized as Safe (GRAS) and Additive Ingredients Regulation (no bill) -Issues related to New Approach Methodologies (NAMs) non-animal technologies used to evaluate drug safety and efficacy
-Issues related to FDA review of active ingredients in over-the-counter products
-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 - Oral Health Products Inclusion Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · fourth_quarter · Q4
-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act
-Issues related to FDA review of active ingredients in over-the-counter products
- U.S. Manufacturing Policy and the USMCA - Industrial Machinery Section 232 Investigation - Issues related to America First Trade Policy/IEEPA Tariffs Executive Orders - China 301 Tariffs, Export Controls, Sanctions - Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) - Personal Protective Equipment and Medical Equipment Section 232 Investigation - Softwood Lumber Section 232 Investigation - Pharmaceuticals Section 232 Investigation - Semiconductors Section 232 Investigation
-Issues related to Generally Recognized As Safe designation
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · third_quarter · Q3
-Issues related to FDA review of active ingredients in over-the-counter products
-H.R.4273: Over-the-Counter Monograph Drug User Fee Amendments (Entire Bill)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · second_quarter · Q2
-Issues related to U.S. Manufacturing
-Issues related to IEEPA Tariffs -Issues related to the Pharmaceuticals Section 232 Trade Investigation -Issues related to Lumber Section 232 Trade Investigation
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
Filing targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · first_quarter · Q1
-Issues related to immigration policy
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 8599, Oral Health Products Inclusion Act
-Issues related to East Coast/Gulf Coast Port Strike -Issues related to federal transportation supply chain & warehousing
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · fourth_quarter · Q4
-Issues related to artificial intelligence
-Issues related to transportation sustainability -Issues related to the East Coast/Gulf Coast Port Strike
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · third_quarter · Q3
-H.R. 471, the SHIP IT Act
-Issues related to U.S. manufacturing (no bill)
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · second_quarter · Q2
-H.R. 471, the SHIP IT Act
-Issues related to counterfeit products
-Issues related to artificial intelligence
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · first_quarter · Q1
-Issues related to sustainability innovations in the transportation sector (no bill)
-Issues related to artificial intelligence
-H.R.471 The SHIP IT Act
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2023 · fourth_quarter · Q4
-Issues related to artificial intelligence
-US Corporate and International Tax Reform (no bill) -OECD Digital Tax Project (Global Minimum Tax Implementation) -OECD Digital Tax Project (Pillar One) -Taxation of Health Benefit Plans (no bill) -US Tax Treaty Negotiations -Taxation of Health Benefit Plans (no Bill)
-Issues related to menstrual products labeling (no bill) -Issues related to maternal health, maternal health equity, black maternal health (no bill)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2023 · third_quarter · Q3
-Issues related to menstrual products labeling (no bill) -Issues related to maternal health, maternal health equity, black maternal health
- H.R.471 SHIP IT Act
-S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2023 · second_quarter · Q2
-Issues related to cleaning products ingredient labeling disclosure bill (no bill introduced) -S.1350 - National Risk Management Act of 2021 -H.R.2964 - WIPPES Act
- H.R.471 SHIP IT Act
-Issues related to maternal health, maternal health equity, black maternal health -Issues related to access to menstrual products (no bill introduced) -Issues related to menstrual products labeling (no bill introduced) -H.R.3646 - Menstrual Equity For All Act of 2023 -H.R.8829 - Menstrual Products Right To Know Act of 2022
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2023 · first_quarter · Q1
-Issues related to flushability and labeling of flushable and non-flushable paper products (no bill introduced) -Issues related to the importance of advanced recycling technologies (no bill)
-Issues related to maternal health, maternal health equity, black maternal health -Issues related to access to menstrual products (no bill introduced) -Issues related to menstrual products labeling (no bill introduced)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
-Issues related to artificial intelligence
-Data Privacy Legislation (No Bill)
-Issues related to labor and employment policy
-Issues related to U.S. Manufacturing
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 471, the SHIP IT Act
-Issues related to labor and employment policy -Antitrust & Competition Policy Issues (No Bill)
-Issues related to U.S. manufacturing (no bill)
-Issues related to visa and related immigration policies (no bill)
-Issues related to ingredient labeling -Issues related to over the counter drug policy
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
-US/Turkey Relations -APEC/US Relations -US/Africa Relations -US/Latin America Relations -UA/Middle East Relations -US/EU Relations
-Issues related to artificial intelligence
-Issues related to transportation sustainability -Issues related to the East Coast/Gulf Coast Port Strike
-Issues related to counterfeit products
-Issues related to labor and employment policy -S.379, Freedom To Compete Act of 2023
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 8818, the American Privacy Rights Act Discussion Draft (data privacy) -Issues related to Advertising and Brand Safety (no bill)
-Issues related to U.S. manufacturing (no bill)
-Issues related to transportation sustainability
-Issues related to labor and employment policy
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
-Issues related to labor and employment -Antitrust & Competition Policy Issues (No Bill)
-General manufacturing, product pricing and supply chain issues (no bill) -Issues related to product packaging
-Issues related to the protection of counterfeit products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
-S.1350: WIPPES Act -H.R.2964: WIPPES Act -Issues related to environmental sustainability
-H.R.471: The SHIP IT Act -Issues related to sustainability innovations in the transportation sector (no bill) -Issues related to intermodal transportation and supply chain challenges (no bill)
-General manufacturing and supply chain issues (no bill) -Issues related to Product Pricing and Supply Chains
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of